What is the role of azithromycin for the treatment of chronic bacterial prostatitis (CBP)?

Updated: May 25, 2021
  • Author: Samantha D Kraemer, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

Azithromycin, a macrolide antibiotic, has reported eradication rates of around 80%. [20] It has good penetration into the prostate and is active against gram-positive bacteria and Chlamydia. It should not be used as a first-line antibiotic but can be used when microbiological studies identify susceptible pathogens. For Chlamydia infections, azithromycin has been reported to be superior to ciprofloxacin with respect to clinical response and eradication rates. [43] Clarithromycin, another macrolide antibiotic, is equivalent to azithromycin in both clinical response and eradication rates. [43]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!